Tephrosia purpurea (Linn.)Pers.- A Comprehensive Review

 

Devprakash1,3*, Sumalatha B.V.1,  K.K. Srinivasan2, Savitha1

1Dept. of Pharmaceutical Chemistry, Bharathi College of Pharmacy, Bharathinagara, K.M. Doddi Karnataka-571422.

2Dept of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal, Udupi, Karnataka-571419.

3Faculty of Pharmacy, Karpagam University, Coimbatore-612001

 

ABSTRACT:

Tephrosia purpurea (Linn.) Pers., a  popular  Indian medicinal plant, has long been used commonly in Ayurvedic and unani system of medicine. In the present review, an attempt has been made to explore a literature survey on its traditional uses, established phytochemical studies and pharmacological properties. The whole plant as well as specific parts such as roots, leaves, seeds and bark have been widely used and shows the different pharmacological activities such as antimicrobial, anti-inflammatory, hepatoprotective,anti-ulcer,anti-epileptic,antibiotic,anticarcinogenic, antilipid peroxidative, wound healing, antidiabetic, antioxidant etc.

 

KEYWORDS: Tephrosia purpurea ,  Traditional  uses,  Phytoconstituents,  Pharmacological  activities.

 

INTRODUCTION:

Medicinal plants have been a major source of therapeutic agents since ancient times to cure human disease. India is considered as “Botanical Garden of the world” and more than 2200 species of medicinal and aromatic plants have been identified after studies. The revival of interest in natural drugs started in last decade mainly because of the wide spread belief that green medicine is healthier than synthetic products. Now-a-days, there is manifold increase in medicinal plant based industries due to the increase in the interest of use of medicinal plants throughout the world which are growing at a rate of 7-15% annually. Despite the major advances in the modern medicine, the development of new drugs from natural products is still considered important. This seems to be even more relevant for the developing countries, where the cost to develop a drug is prohibitive. Since 1980, the World Health Organization has been encouraging countries to identify and exploit traditional medicine and phytotherapy. The Indian Traditional systems of medicine namely Ayurveda and Siddha are primarily plant based system. The evaluation of new drugs especially phytochemically obtained materials has again opened a vast area for research and development. As per WHO, about 80% of the population in the world relay on the traditional medicine for the treatment of various diseases. Therefore, the evaluation of rich heritage of traditional medicine is essential1.

 

In this regard, one of the such plant is Tephrosia purpurea (Linn.) pers,  (fig:4)belongs to family Fabaceae, and it is a highly branched suberectherbaceous perennial, upto60 m in height with spreading branches; the leaves are imparipinnate, with narrow, oblanceolate leaflets; the flowers are red or purple in extra-axillary racemes, the pods are slightly curved, 3-4.5 cm long, grey, smooth and containing 5-10 seeds per pod. The plant grows abundantly in the upper Gangeticplains, and western Himalayas. The herb is commonly grown as a green manure in paddy fields in India and in tobacco and rubber plantation in other countries.


It grows uniquitouslyin all soils, sandy, rocky, and loamy. In India and South Africa, it is used as a fodder before flowering, but in Australia it is reported to cause livestock poisoning2.

 

Tephrosia purpurea Linn. is commonly known as wild indigoin English, Kolanjiin Tamil, sharapunkhain Sanskrit, Sarponkhain Hindi, Thilain Gujarati, Vempaliin Telugu3-4-5 . According to Ayverveda literature this plant has also given the name of wranvishapakawhich means that it has the property of healing all types of wounds6.It has been used in Ayurvedic system, Siddha, unani system of medicine for the treatment of various diseases. Experimental studies suggest that Tephrosia purpurea Linn exerts anti-ulcer, anti-oxidant, hepatoproductive and hypoglycaemic activities. It has been reported to possess hepatoprotective and mast cell stabilising effect in various experimental models7.

 

Species  of Tephrosia

The genus Tephrosia is a Pantropical taxa with about 400 species distributed chiefly in Asia, Africa, Australia. Tephrosia belongs to the family Fabaceae (Leguminosae) and has earlier been classified by many taxonomists either into sections of subgenera, based mainly on the morphological traits classified Tephrosia into four sections namely Mundulea, Brissonia, Croccoides and Reineria. Of these only mundulea and Reineria, which includes rest of species of Tephrosia. Wood categorized the new world species of Tephrosiainto groups, one with a glasrous style and the other with a pubescent style. Gillett adopted this classification in African species of Tephrosia. Subseguently Brurnmitt divided Tephrosiainto subgenera, subg. Tephrosia with a glabrous style (according to which T. hamiltonii, T. Pumila, T. purpurea, T. spinosa, T. Strigosa, T.villosa etc. Were included) and subg. Barbisyla with a trichiferous style (which includes T. candida, T. maxima, T. pulcherima, T. tinctoriaetc). The above classification was criticized since same of the taxa (T. pumila T. maxima etc.) showed bothglabrous and trichiferous styles8.  

 

Other species of  Tephrosia

Tephrosia vogelii

1.       Tephrosia kerrii

2.       Tephrosia vestita

3.       Tephrosia noctiflora

4.       Tephrosia ionophlebia

5.       Tephrosia coccinea

6.       Tephrosia luzonensis

7.       Tephrosia obovata.

 

Tephrosia kerrii

Herbs, perennial, to 3 m tall, densely yellow spreading villous. Stems erect, sturdy, ridged, apically branched. Leaves 11–17-foliolate; rachis 9–15 cm, including petiole ca. 5 mm; leaflet blades oblong-lanceolate, 5–8 × 1.5–2 cm, abaxially densely silverysericeous, adaxially olive-green and glabrous, secondary veins 20 on each side of midvein and conspicuous, base obtuse to cuneate, apex acute and cuspidate. Pseudoracemes terminal, when immature cone-shaped and covered by bracts, elongated to ca. 10 cm at anthesis. Pedice ca. 5 mm, densely white sericeous. Flowers ca.2.2 cm. Calyx ca. 8 × 6 mm; teeth narrowly triangular, most abaxial one longest and ca. 5 mm apex acute. Corolla red; standard obovate, yellow sericeous. Ovary sericeous, with numerous ovules. Legume linear, 8–10 cm × 6–8 mm, straight, spreading and slightly nodding, yellow sericeous, apex with a ca. 1 cm slightly ascending beak. Seeds 10–12 per legume but characters unknown.

 

Tephrosia vestita

Herbs, perennial, suffrutescent, 1–2 m tall, many branched, yellowish white velutinous. Stems zigzag ascending, ridged. Leaves 7–11 (or 13)-foliolate; rachis ca. 10 cm, including petiole1–1.5 cm; leaflet blades obovate-elliptic to narrowly elliptic, 2–4 × 1–1.8 cm, abaxially velutinous, adaxially rough and glabrous, secondary veins 15–20 on each side of midvein, base cuneate, apex rounded to retuse. Pseudoracemes terminal or opposite leaf near apex of branchlets, 3–7 cm, with congested flowers. Pedicel ca. 2 mm. Flowers ca. 1.7 cm, fragrant. Calyx ca. 3× 4 mm. Corolla white; standard suborbicular, yellow velutinous. Ovary sericeous, with numerous ovules. Legume linear, 5.5–6 cm × ca. 5 mm, straight, flat, densely yellow velutinous, apex abruptly pointed and with a ca. 1 cm beak. Seeds 10–12per legume, black, reniform, ca. 3 × 2.5 mm.

 

Tephrosia coccinea

Herbs, perennial, suffrutescent, 40–50 cm tall, many branched. Stems woody, terete; young branchlets 4-sided, silveryor white appressedsericeous. Leaves subsessile, 5- or 7(or9)-foliolate; rachis 6–10 cm; leaflet blades linear-oblanceolateto oblong-oblanceolate, 4–6 × ca. 1 cm with basal pair smallest and terminal one longest, abaxially silvery sericeous, secondary veins 9 or 10 on each side of midvein. Pseudoracemes terminal or opposite a leaf, ca. 25 cm, with scattered flowers. Pedicel 3–6 mm. Flowers ca. 1 cm. Calyx ca. 5 mm. Corolla red; standard orbicular, outside sericeous, inside glabrous. Ovary stipitate, sericeous, with 10–12 ovules. Legume linear, ca. 6 cm × 7–8 mm, flat, tomentose. Seeds 8–12 per legume, black, reniform, ca. 8 × 5 mm.

 

Tephrosia pumila

Herbs, annual or perennial, procumbent or straggling, 20–30 cm tall. Stems thin and hard, ridged, densely spreading strigose. Stipules 3–4 mm. Leaves 7(–13)-foliolate; rachis 2–4 cm, including petiole 3–10 mm; leaflet blades narrowly obovatetooblanceolate, 1.2–2 × 0.4–0.8 cm, abaxiallystrigose, adaxially appressed pubescent, secondary veins 6 or 7 on each side of midvein and obscure, base cuneate, apex truncate to obtuse and cuspidate. Pseudoracemes terminal or opposite a leaf, ca. 2 cm, strigose, with 1–3 flowers. Pedicel 2.5–4 mm. Flowers ca. 6mm. Calyx ca. 3 × 2 mm. Corolla white, yellow, or rarely palepink; standard orbicular, pilose. Ovary withtrichomes, with numerous ovules. Legume linear, 3.5–4 cm × ca. 4 mm, shortly strigose, apex slightly ascending curved and

with a beak; styleremnant sharply reflexed. Seeds 8–14 per legume, brown, oblong-rhomboid, ca. 4 × 3 mm, mottled.

Tephrosia noctiflora

Herbs, perennial, suffrutescent, 0.5–1.5 m tall. Stems terete, with dense spreading trichomes. Stipules narrowly triangular, 6–11 mm, persistent, apex acuminate. Leaves 15–25-foliolate; rachis 7–11 cm, including petiole 0.7–1.3 cm; leaf letblades oblong-oblanceolate, 2.2–3.2 × 0.5–0.8 cm with terminalone slightly larger than others, abaxially densely appressedsericeous, adaxiallyglabrous, secondary veins 9–11 on each side of midvein, base cuneate, apex rounded to retuse and cuspidate. Pseudoracemes terminal, 15–25 cm, rigid and straight, with scattered flowers. Pedicel 2–4 mm. Flowers ca. 1 cm. Calyx ca. 5 ×5 mm, densely brown pubescent; teeth unequal, most abaxialone 4–6 mm and narrow, other ones short and broad. Corolla yellow, violet, or white; standard orbicular, brown sericeous. Ovary sericeous, with numerous ovules. Legume linear, 4.5–5 cm × ca. 5 mm, straight, densely brown pubescent, apex ascending curved. Seeds 7–9 per legume, black, reniform, ca. 4× 2.5 mm, usually transversely rugose.

 

Tephrosia pumila

Herbs, annual or perennial, procumbent or straggling, 20–30 cm tall. Stems thin and hard, ridged, densely spreading strigose. Stipules 3–4 mm. Leaves 7(–13)-foliolate; rachis 2–4 cm, including petiole 3–10 mm; leaflet blades narrowly obovate to oblanceolate, 1.2–2 × 0.4–0.8 cm, abaxiallystrigose, adaxially appressed pubescent, secondary veins 6 or 7 on each side of midvein and obscure, base cuneate, apex truncate to obtuse and cuspidate. Pseudoracemes terminal or opposite a leaf, ca. 2 cm, strigose, with 1–3 flowers. Pedicel 2.5–4 mm. Flowers ca. 6 mm. Calyx ca. 3 × 2 mm. Corolla white, yellow, or rarely pale pink; standard orbicular, pilose. Ovary with trichomes, with numerous ovules. Legume linear, 3.5–4 cm × ca. 4 mm, shortly strigose, apex slightly ascending curved and with a beak; styleremnant sharply reflexed. Seeds 8–14 per legume, brown, oblong-rhomboid, ca. 4 × 3 mm, mottled.

                                    

Tephrosiao bovata

Herbs, perennial, small. Stems straggling, appressed pubescent, base woody. Stipules subulate, 2–4 mm. Leaves (9or) 11- or 13-foliolate; rachis ca. 5 cm, including petiole ca. 1.5 cm; leaflet blades obovate, ca. 1.4 × 0.6 cm, both surfaces appressedsericeous but abaxially especially dense,

 

secondary veins 5–8 on each side of midvein and obscure,

base roundedcuneate, apex emarginate and cuspidate. Pseudoracemesterminalor axillary, short. Flowers ca. 1 cm. Calyx campanulate, ca.3 mm. Corolla red; standard orbicular, outside pubescent. Ovary withtrichomes. Legume linear, 2–2.5 cm × ca. 4 mm, straight, densely velutinous. Seeds 6 or 7 per legume, pale brown, ellipsoid, ca. 2.5 × 2.2 mm.

 

Tephrosia purpurea

Plants ± pubescent. Stipules ca. 4 mm. Leaflet blades oblong-elliptic to oblanceolate-elliptic, 1.5–3.5 × 0.4–1.4 cm, abaxially appressed pubescent, adaxiallyglabrous. Racemes ca.10 cm, slender. Legume 4–5 cm × 4(–6) mm, with trichomes. Seeds grayish brown, spotted, smooth9.

 

Taxonomy, Morphological and Microscopic characteristics of Tephrrosia purpurea

Taxonomy

Tephrosia purpurea(Linn.) Pers. belongs to the family Fabaceae, occurs throughoutthe Indian subcontinent, thrives well in sandy or loamysoils and also in rocky areas. Tephrosia purpurea (Linn.) Pers.is a copiously branched herbaceous perennial, 30-60cm high, branches spreading, glabrousor sparsely pilose. Leaves 5-10 cm long, petioles 6-12 mm long, stipules linear-subulate, nerved, erect or sometimes reflexed. Leaflets11-21, oblanceolate, obtuse or retuse, mucronate, size ofleaflets varies from 2-2.8 by 0.8-1.2 cm, glabrousabove, clothed with fine appressed silky hair beneath, base cuneate; nerves close, ascending, slender, conspicuous on bothsurfaces; petiolulesof lateral leaflets 1.5-2.5 mm long.

 

Tephrosiapur purea roots were 8 to 25 cm long, cylindrical, tortuous, tapering and branched with lateral roots;bitter in taste, 0.4 to 4 cm in diameter, surface rough, longitudinally wrinkled and cracked, at places transversely cracked exposing the inner light solid wood. Scars left by the removal of the lateral roots are so prominent, externally brownish yellow, internally pale yellow. Smooth transversely cut surface of the root is circular with thin cork and narrow cortex. Many lateral roots with 2 to 6 cm long, fibrous, externally and internally brownish and pale brown in color respectively.

 


Morphological and Microscopic characteristics of Tephrosiapurpurea root

Macroscopic characters

 

 


Microscopic  characteristics

Transverse section of Tephrosia purpurea root

Transverse  section  of  mature  root  showed  a  well developed  periderm  consisting  of  6  to  10  layers  of  cork  cells,2  to  4  layers  of  phelloderm  and  several  layers  of  cortex. Cork  cells  are  tangentially  elongated  and  suberised. Phelloderm  is  composed   of  thin-walled  parenchymatous  cells  filled  with  starch  grains  and  prisms  of  calcium oxalate crystals. Cortex  has  parenchymatous  cells  containing  prisms  of  calcium  oxalate  crystals  and  starch  grains. Groups of thick walled pericyclic fibres are present at the lower end of cortex. Thick walled fibres, solitaryor in groups of two ormore were present in phloem.

 

 

Photoplate shows various layers in roots 10x (figure2a) and xylem and medullary rays in roots 40x (figure 2b)Many cells containing prisms of calcium oxalate crystals are associated with each group of fibres; starch grains are present in phloem parenchyma. Xylem vessel elements distributed singly or in groups of 2 to 4. Starch grains and prisms of calcium oxalate crystals are present in the medullary ray cells. The microscopic characters of roots can serve as diagnostic character and helpful in differentiation of species as well as identification of particular herb. We observed some morphological characters like number of leaflet is varied from one region to another region. Most of the microscopical characters of Tephrosiapurpurea roots are almost similar except we found the reticulate xylem vessel in our study. (Figure 2)

Powder characteristic of Tephrosia purpurea root

Powder was light brown in colour and odor was not characteristic. It was slightly bitter in taste. Microscopic study of powder showed various characters such as phloem fibres, concentric starch grains, pitted and border pitted xylem vessels, reticulate xylem vessels, crystal fibres and groups of cork cells shown in Figure 3.

 

Formulations  ofTephrosia purpurea

1. Routack

Routack is one such polyherbal formulation containing the whole dried plant  of Tephrosiapurpurea. These ingredients have specific properties thatmay be useful in ameliorating the pathophysiology   of   anaphylaxis.  The protective effect of this formulation in two different rodent models of anaphylaxis. The models represented the condition developed during an anaphylactic attack. In both these  studies, the results suggested that routack offered significant protective effect against anaphylaxis, albeit at higher doses. The polyherbal formulation exhibited substantial protective effect against triple antigen induced anaphylaxis in rats. Routack was uncovered of its activity against systemic anaphylaxis induced by mast cell secretagogue, compound 48/80. This effect can be translated to the clinical side if the formulation can be incorporated as a dietary supplement in patients who are at risk of developing anaphylaxis. The  200  mg/kg  and  400  mg/kg  of  routack  was  showed  significant  protective  effect11. 

 

2. Livergen

Polyherbal  formulations  available  with  a  wide  range  of  indications  like  protective  to  liver, appetite  and  growth  promoters,  gastrointestinal  and  hepatic  regulator,  as  treatment  for  hepatic dysfunction,  for  hepatic  regeneration  as  well  as  liver  stimulant  and  tonic.  Despite  the  widespread  use,  there  is  a  lack  of  scientific  evidence  on  their  efficacy  and  safety. A polyherbal hepatoprotective formulation, namely Livergen  was selected  from Tephrosia purpurea. The criteria for selection was based on (i) claimed as Ayurvedic medicine, (ii)commercially available, (iii) liquid formulations for easy administration, (iv) with known hepatoprotective and (v) sufficient shelf life. This herbal drug have been traditionally used for liver diseases and the polyherbal formulations, claimed to be Ayurvedic medicines are being sold as liver tonics. The  polyherbal hepatoprotective  formulation  Livergen  was effective  as   hepatoprotective  agent  in  normal  dose (2.60 ml/kg bw, orally).  The Polyherbal formulation Livergen had shown significant  hepatoprptective  activity  by decreasing  the  enzyme  level  of  SGOT,  SGPT,  ALP,  Cholesterol,  Bilirubin  and  significant  increase  in  enzyme  level  of  Total protein  (P< 0.01)12.

 

3. Hepjaun (HA-I)

HA-I  is  one  of  the  well  known  proprietary  polyherbal  formulation,  containing  aqueous  extracts  of Tephrosia purpurea crude drugs.  The  Hepatoprotective  activity  of  Hepjaun  syrup  (HA-I)  and  Modified  Formulations  (HA-II  and  HA-III)  were  evaluated  and  compared  statistically  after  inducing  hepatotoxicity  in  rats  by subcutaneous  administration  of  carbon tetra chloride  (CCL4)  with  olive oil  as  a  diluent  in  1:1  %v/v  on  2nd  and  3rd  day.  The  liver  damage  was  confirmed  by  estimation  of  elevated  levels  of  Serum  Glutamate  Oxaloacetate  Transaminase  (SGOT),  Serum  Glutamate  Pyruvate  Transaminase  (SGPT),  Alkaline  Phosphatase  (ALP),  serum  bilirubin  and  liver  weights.  HA-I, HA-II,  HA-III  pretreatment  (500mg/kg)  significantly  reduces  the  CCl4  induced  elevated  serum levels  of  SGOT,  SGPT,  SALP  and  Serum  Bilirubin13.

 

Traditional uses

In the Ayurvedic system of medicine, various parts of this plant are used as remedies for impotence, asthma, diarrhoea, gonorrhoea, rheumatism, ulcers and urinary disorders. The plant has been claimed to cure diseases of kidney, liver, spleen, heart, and blood. The dried herb is effective as a tonic laxative, diuretic, and deobstruent. It is also used in the treatment of bronchitis, bilious febrile attacks, boils, pimples and bleeding piles. The roots and seeds reported to have insecticidal and piscicidal properties and they are also used as a vermifuge. In addition, the roots are reported to be effective in the treatment of leprous lesions while their juice is used to treat skin eruptions. An extract of the pods is effective for the treatment of pain, inflammation and their decoction is used to combat vomiting14.  The  roots  are  useful  in  inflammation,  skin  diseases,  scrofula,  elephantiasiasis,  dyspepsia,  stomachalgia,  flatulence,  haemorrhoids,  asthma,  bronchitis,  ananemia,  hepatosplenomegaly,  verminosis,  strangury,  dysmenorrhoea,  chronic  fever,  boils,  pimples,  odontalgia  and  gingivitis.  In  traditional  Indian  medicine,  Tephrosiapurpurea  is  a  common  ingredient  of  formulations  for  liver  ailments  and  used  for  different  remedies  such  as  bilious  febrile  attacks,  liver  and  splenic  affections,  cirrhosis,  hepatitis,  piles,  syphills  and  gonorrhoea.  It  is  considered  beneficial  for  liver,  kidney,  and  spleen  disorders15.

 

Phytochemical studies

The preliminary phytochemical study investigation of all the extract shows the presence of Anthraquinone. Pet ether and ethanol extract shows presence of alkaloids, steroids and sterols, triterpenoids and fixed oil. Ethanol and aqueous extracts shows the presence of flavonoids, while as aqueous extract shows presence of carbohydrate, Protein, Amino acid, tannins and phenolic compounds and saponins16.The plant of Tephrosia purpurea Linn also shows the presence of glycosides, rotenoids, isoflavones, flavanones, chalcones, flavanols, flavones and sterols17,coumarins, quercetins18.

 

Flavonoids  like tephrosin, pongaglabol and semiglabrin have been isolated from aerial parts of the plant19. Recently invented constituents are as an isoflavone, 7,4-dihydroxy-3,5-dimethoxyisoflavone, and a -tephropurpurin,  lanceolatin B, maackiain, 9-methylene-dioxypterocarpan, medicarpin, rotenone, deguelins. Three novel flavonoids, (+)-tephrosinsA, and B and (+)-tephrosone, were also isolated from Tephrosia purpurea. The leaves contain up to 2.5 rutin7,2% glycoside osyritin, β-sitosteroland lupeoland root contain isotephrosin20.

 

Rotenoides and flavonoides like isolonchocarpin and lanceolatin A, lanceolatinB21, Purpurenone, a new β-hydroxychalcone, (+)-purpurin, a diasteroisoer of (-)-purpurin, dehydroisodernicin, and (-)-maackiain have been isolated from roots of Tephrosia purpurea22. A new flavone, psedosemiglabrinolhas been isolated along with semiglabrino[23.Two new prenylated flavonoids, purpuriteninand purpureamethide, have been characterised from the seeds of Tephrosia purpurea together with the known compounds karanjin, kanjone and sitosterol24. Flavonolslike karanjonoland dibenzoyl methanes like o-methylpongamolhave been isolated from plant of Tephrosia purpurea25.

 

A new prenylated flavone, named terpurin flavones has been isolated from the stem of  this plant26.A new flavanone purpurin has been isolated from benzene extract27and pongamol in its pure enol form has been isolated from the petrol and benzene extracts of whole plant together with β-sitosterol, ursolic acid and spinasterol by column chromatography28.  

 

Pharmacological studies

Antibacterial activity

The  methanolic  extract  of  roots  was  evaluated  by  Gupta  at al29,  for  its  in  vitro  antimicrobial  properties  by  agar  disc  diffusion  method.  The crude  methanolic  extract  of  Tephrosia purpurea at  the  concentration  ranging  between  250  µg/ml  and  1000  µ/ml  inhibited  the  growth  of  both  Gram  positive  bacteria  (Bacillus  subtilis,  Staphylococcus aureus  pers.  Micrococcus  luteus)  and  Gram  negative  bacteria  (Escherichia coli,  Pseudomsonas aeruginosa  and  Salmonella  typhimurium).  The  Gram  positive  bacteria  tested  appeared  to  be  more  susceptible  to  the  extract  than  the  Gram  negative  bacteria.  The  extract  also  showed  significant  antifungal  activity  against Aspergillus niger  and  Candida  albicans.

 

In  another  study  by  Abayasekara30,  ethanolic  root  extracts  of  Tephrosia  purpurea were  found  to  be  active  against  p.  Aeruginosa,  two  other  pseudomonas  strains  and  two  coliform  strains.  Priliminary  testing  of  antimicrobial  activity  of  T.  Purpurea against  3  standard  cultures  (Staphylococcus aureus, Pseudomonas  aeruginosa,  E.  Coli) and one   clinical isolate of Candida  spp.  Was  performed  with  water  extracts  of  leaves,  pods  and  roots  using  the  ‘disc  diffusion  bioassay’.  Subsequently,  the  antimicrobial  activity  of  ethanolic root  and  leaf  extracts  against  the  above  three  standard  isolates  and  clinical  isolates  of  two  strains  of  Staphylococcus,  two  strains  of  Pseudomonas  and  nine  coliforms  were  tested  using  the  ‘well  method’.  The  active  extracts  were  subjected  to  the  Minimum  Inhibitory  Concentration  agar  dilution  of  each  extract.  The  ethanolic  extract  of  Tephrosia purpurea (128  mg/dm3)  showed  the  significant  antibiotic  activity  against  the  two  strains  of  Staphylococcus,  two  strains  of  pseudomonas and  nine  coliforms.

 

Anti-inflammatory   activity

The  ethanolic  extract  of  orally  administered  Tephrosia purpurea  was  evaluated  by  Shenoy Smitha at  al31,  for  its  anti-inflammatory  activity  inacute  and  sub acute  inflammation.  Carrageenan  induced  paw  edema  and  cotton  pellet  granuloma  were  the  two  models  for  acute  and  subacute  inflammation.  The  ethanolic  extract  of  orally  administered  Tephrosia purpurea  (100mg/kg)  significant  anti-inflammatory  effect  in  sub acute  inflammation  but  not  in  acute  inflammation  in  rats  by  comparing  with  standard  aspirin.

 

In  another  study  by  Gopalakrishna32,  ethanolic  extracts  of  Tephrosia purpurea (250,  500mg/kg,  b.w)  roots  and  aerial  parts  shows  significant  in  acute  and  sub acute  as  well  as  analgesic  activity  by  tail  immersion  method.  Furthermore,  the  activities  of  the  plant  extracts  were  compared  with  the  standard  indomethacin  (20mg/kg,  ip).    

 

Sree  Rama  Murthy at  al33,  studied  the  hepatoprotective  effect  of  Tephrosia purpurea  in rats  by  inducing  hepatotoxicity  with  D-galactosamine HCl  (acute)  and  carbon  tetrachloride  (chronic).  Tephrosia purpurea  (aerial  parts)  powder  was  administered  orally  at  a  dose  of  500mg/kg.  Serum  levels  of  transaminases  (SGOT and  SGPT)  and  bilirubin  were  used  as  the  biochemical  markers  of   hepatotoxicity.  Histopathological  changes  in  the  liver  were  also  studied.  The  results  of  the  study  indicated  that  the  administration  of  tephrosia  along  with  the  hepatotoxins  offered  a  protective  action  in  both  acute  (D-galactosamine)  and  chronic  (CCl4)  models.

 

In  another  study  by  Jain34,  ethanolic  extract  of  leaves  and  flavonoid  (isolated  from  leaves  extract)  from  Tephrosia purpurea  were  evaluated  for  hepatoprotective  activity  in  rats  by  inducing  hepatotoxicity  with  carbon  tetrachloride.  These  fractions  were  administered  orally  at  a  dose  100  mg/kg/day.  Serum  level  of  transaminases,  alkaline  phosphate,  and  total  bilirubin  were  used  as  biochemical  markers  of  the  study  indicated  that  the  hepatoprotective  changes  in  the  liver  were  also  studied.  The  results  of  the  study  indicated  that  the  hepatoprotective  activity  was  more  in  ethanolic  extract  of  leaves  than  isolated  flavonoid. 

 

Antihyperglycimic  andAntilipidperoxidative  activity

Sethupathy at  al35,  studied  the  antihyperglycemic  and  antilipidperoxidative  effects  of  ethanolic  seed  extract  of  Tephrosia purpurea  (TpEt)  in  streptozocin  induced  diabetic  rats.  Hyperglycemic  associated  with  an  altered  hexokinase  and  glucose  6  phosphatase  activities,  elevated  lipid  per oxidative,  disturbed  enzymatic  and  non-enzymatic  antioxidants  status  were  observed  in  streptozotocin  induced  diabetic  rats.  Oral  administration  of  TpEt  at  a  dose  300mg/kg  bw  showed  significant  antihyperglycemic  and  antilipidperoxidative  effects  as  well as  increased  the  activities  of  enzymatic  antioxidants  and  levels  of  non  enzymatic  antioxidants.  The  antihyperglycemic  effect  of  plant  drug  (TpEt)  was  comparable  to  that  of  the  reference  drug  glibenclamide.

 

Antiepileptic  activity

The  ethanolic  extract  of  the  Tephrosia purpurea  was  found  to  be  useful  to  be  useful  to  control  lithium-pilocarpine status  epilepticus  in  albino  rats  of  wistar  strain.  Status epilepticus  was  induced  in  male  albino  rats  of  wistar  strain  by  administration  of  pilocarpine  (30mg/kg,  i.p.)  24  after lithium  chloride  (3mEq/kg,  i.p).  Different  doses  of  the  extract  of  Tephrosia purpurea  were  administered  orally  one  hour  before  the  injection  of  pilocarpine.  The  severity  of  the  status  epilepticus  was  reduced  with  the  administration  of  ethanolic  extract  of  Tephrosia purpurea (250, 500, and  1000mg/kg) orally36.

 

Anti-helicobacter  pyroli  activity

The  methanolic  extract (50µg/ml  or  25µl)  showed  promising  activity  against  clinical  isolates  and  standard  strains  of  Helicobacter  pyroli,  including  metronidazole-resistant  strains.  Fractionation  of  the  extract  revealed  the  n-hexane  and  chloroform  fractions  to  possess  marked  activity.  The  extract  and  the  less  polar  fractions  remained  functionally  active  in  acidic  condition  similar  to  stomach  environment,  exhibited  consistent bacteriostatic  activity  during  repeated  exposure,  and  demonstrated  synergism,  complete  or  partial,  even  with  antibiotic-resistant  strains37.

 

Antihyperlipidemic  activity

The  ethanolic  extract  of  leaves  of  Tephrosia purpurea  Linn.  was evaluated   the  lipid  lowering  properties  on  experimentally  Dexamethasone  induced  rats.  The  lipid  parameters  studied  are  Total  cholesterol(TC),  low  density  lipoprotein  cholesterol  (LDL-C),  High  density  lipoprotein  cholesterol  (HDL-C),  very  low  density  lipoprotein  cholesterol  (VLD-C),  Triglycerides  and  atherogenic  index.  Extract  was  administered  orally  for  eight  days  at  a  dose  of  600  and  1200mg/kg  in  Dexamethasone  induced  rats.  The   level  of  TC,  LDL-C,  VLDL-C,  and  Triglycerides  were  reduced  significantly.  (p<0.001)  while  HDL-C  level  was  significantly  increased  when  compared  to  control  groups  of  rats.  In  conclusion  these    suggested  that  ethanolic  extract  of  leaves  of  Tephrosia purpurea  Linn.  can reduce  the  lipid  levels  significantly38.

 

Antiulcer  activity

Theaqueous  extract  (1  to  20  mg/kg)  of  roots  of  Tephrosia purpurea  (AETP)  showed  significant  antiulcer  activity  in  rats  in  which  gastric  ulcers  were  induced  by  oral  administration  of  ethanol  or  0.6  M  HCL  or  indomethacin  or by  pyrolic  ligation  and  duodenal  ulcers  were  induced  by  oral  administration  of cysteamine  HCL.  AETP  was  administration  in  the  dose  of  1  to  20  mg/kg  orally  30  min  prior  to  ulcer  induction.  The  antiulcer  activity  was  assessed  by  determining  and  comparing  the  ulcer  index  in  the  drug  group  with  that  of  the  vehicle  control  group.  Gastric  total  acid  output  and  pepsin  activity  were  estimated  in  the  pylorus  ligated  rats.  Omeprazole  was  used  as  a  reference  drug39.

 

Antioxidant  activity

The  ethanolic  extract  of  Tephrosia purpurea (100,  200,  and  400mg/kg)  exhibits  antioxidant  activity  in  vivo  and  the  ethyl  acetate  soluble  fraction  has  improved  antioxidant  potential  than  the  extract.  The  ethyl  acetate  fraction  of  the  same  extract  was  studied  for  free  radial  scavenging  and  antilipidperoxidation  activity.  The  IC50  values  in  both  of  these  in vivo  assays  were  found  to  be  significantly  reduced  for  ethyl  acetate  fraction  compared  with  the  ethanolic  extract  of  the  plant.  The  observation  was  further  supported  by  comparing  the  in vivo antioxidant  activity  for  both  the  ethanolic  extract  and  its  ethyl  acetate  fraction40.

 

Wound  healing  activity

The  plant  Tephrosia purpurea  was  found  to  be  effective  in  healing  external  wounds.  Wound healing  potential  of  ethanolic  extract  of Tephrosia purpurea  (5%  w/w)  (aerial  part)  in  the  form  of  simple  ointment  using  three  types  of  wound  models  in  rats  as  incision  wound,  excite on  wound  and  space  wound.  The  results  were  comparable  to  standard  drug  fluticasone  propionate  ointment, in  terms  of  wound  contraction,  tensile  strength,  hitopathological  and  biochemical  parameters  such  as  hydroxyproline  content,  protein  level,  etc41.

 

Anti-allergic  activity

The  ethanolic  extract  of  the  aerial  parts  of  Tephrosia purpurea  administered  orally  at  a  doses  of  50,100  and  200  mg/kg,  significantly  reduced  an  elevated  WBC  count  in  response  to  antigen  challenge  in  sensitized  mice.  The  extract  also  significantly  inhibited  eosinophil  infiltration  without  any  significant  change  in  the  mononuclear  cell  population.  The extract  failed  to  alter  neutrophil  adhesion  to  nylon  fibres.  However,  it  produced  a  significant  inhibitory  activity  on  enzyme  lipoxygenase  at  concentrations  of  100  and  200  µg/ml.  The  inhibitory  effect  of  ethanolic  extract  of  Tephrosia purpurea  on  late-phase  allergy  could  be  attributed  to  the  inhibition  of  leukotriene  synthesis42.

 

Anticarcinogenic  activity

The  ethanolic  root  extract  of Tephrosia purpurea  (Linn.)  Pers.  (TpEt)showed  the  chemo preventive  potential  on  7,  12-dimethylbenz(a)anthracene  (DMBA)-  induced  hamster  buccal pouch  carcinoma.  Oral  administration  of  TpEt  at  a  dose  of  300mg/kg,  b.w.,  to  DMBA  (on  alternate  days  for  14  weeks)-  painted  animals  significantly  prevented  the  incidence,  volume  and  burden  of  the  tumor43.

 

Anthelmintic  activity

The  Pet  ether,  Ethanol,  Aqueous  extracts  of  seeds  of Tephrosia purpurea   Linn.  exhibited  anthelmintic  activity  in  dose-dependent  manner  giving  shortest  time  of  paralysis  and  death  with  100mg/ml  concentration  for Pheretima posthuma.  Pet ether  extract  cause  paralysis  of  27min  and  earthworm  remain  alive  for  60  min.,  the  aqueous  extract  shows  paralysis  within  10.4  min  and  time  of  death  46.2  min  and  the  ethanolic  extract  of  Tephrosia purpurea  Linn.  cause  paralysis  within  5.4  min  and  time  of  death  10.6  min.  Ethanolic  extract  (50,  100mg/ml)  was  found  to  be  most  potent  among  the  all  extract44.

 

Anxiolytic  activity

The hydroalcoholic  extract  of  Tephrosia purpurea  (L)  Pers  (HAETP)  was  evaluated  the  anxiolytic  activity  in  mice  using  the  elevated  plus-maze  (EPM),  elevated  zero-maze(EZM),  Y-maze  and  hole-board  models.  Furthermore,  the  anxiolytic  effects  of  HAETP  were  compared  to  a  known  active  anxiolytic  drug  diazepam.  The  extract,  administered  orally,  in  two  different  doses  of  HAETP  200mg/kg  and  400  mg/kg,  was  able  to  increase  the  time  spent  and  the  number  of  arm  entries  in  the  open  arms  of  the  elevated  plus-maze  and  elevated  zero-maze,  as  well  as  decrease  the  visits  by  mice  in  the  Y-maze,  also  significantly  increase  nose  poking,  line  crossing  and  rearing  in  hole-board.  This  effect  was  comparable  to  that  of  the  diazepam  (2.0mg/kg).  These  results  indicate  that  hydroalcoholic  extract  Tephrosia purpurea  (L)  Pers  is  an  effective  anxiolytic  agent45.

 

CONCLUSION:

In  recent  years,  ethnobotanical  and  traditional  uses  of  natural  compounds,  especially  of  plant  origin  received  much  attention  as  they  are  well  tested  for  their  efficacy  and  generally believed  to  be  safe  for  human  use.  They  obviously  deserve  scrutiny  on  modern  scientific  lines  such  as  phytochemical  investigation,  biological  evaluation  on  experimental  animal  models,  toxicity  studies  and  investigation  of  molecular  mechanism  of  actions  of  isolated  phytoconstituents.  Tephrosia purpurea  is  reported  to  possess  antibacterial,  anti-inflammatory,  hepatoprotective,  antihyperglycemic,  antilipidperoxidative,  antioxidative,  antiallergic,  anticarcinogenic,  anti-helicobacter  pyroli,  antiulcer,  antihyperlipidemic,  antiepileptic,  wound  healing,  anxiolytic  and  anthelmintic  activities  but  number  of  other  pharmacological  activities  are  yet  to  be  explored.  The  review  emphasis  on  the  utility  of  Tephrosia purpurea in  Ayurvedic  well  established  now  in  modern  medicine  system.  In  future  studies,  the  isolated  principles  from  different  parts  of  the  plant  needs  to  be  evaluated  in  scientific  manner  using  specific  experimental  animal  models  and  clinical  specific  experimental  animal  models  and  clinical  trials  are  to  be  bone  to  understand  the  molecular  mechanism  of  action,  in  search  of  lead  molecule  from  natural  resources.     

 

REFERENCES

1.        Paarakh  PM: Negellasativa  Linn.-  A  comprehensive  review.  Ind J Nat prod Res  2010;1(4):409-429.

2.        Khalafalah  AK,  Yousef  AH,  Esmail  AM, Abdelrazik  MH,  Mohamed  HH  at  al.,  studied  the  Chemical  constituents  of  Tephrosia purpurea, Pharmacognosy  Research  2010;2(2):1-3.

3.        Gopalakrishna S, Vadivel E,  and  Dhanalaskshmi.Phytochemical  andpharmacognostical  studies  of  TephrosiapurpureaLinn.  aerialand  root  parts.  J  Herbal  MedToxicol 2009;3(2):73-78. 

4.        Hegazy M-EF.Rare prenylated flavonoids  from Tephrosia purpurea.  Phytochemistry  2009;70:1474-1477. 

5.        Patel  A,  Amit  P and  Patel  NM.  Estimation  of  Flavonoid,  Polyphenolic  Content  and  In-vitro  Antioxidant  Capacity  of  leaves  of Tephrosia purpurea.  IJPSR  2010;1(1):66-77.

6.        Devprakash,  Srinivasan  KK,  Subbaraju  T,  Sachin  KS.  Antimicrobial  Activity  of  Alcoholic  and  Aqueous  Extracts  of  Tephrosia purpurea. Asian J Biochem Pharma  Res2011;2(1): 670-675.

7.        Sandhya  S,  Venkatramana  K,  Vinod  KR,  Chaitanya  RK,  Chandrasekhar  J at  al.,  studied  the  Membrane  stabilizing  potency  of  two  Tephrosia  species.  J  Phytol  2010;2(6):42-46.

8.        Lashmi  P,  Khan  AA,  Reddy  PN,  Lakshminarayana  K,  Ganapaty  S.  Genetic  relationship  Among  Tephrosia species  as  Revealed  by  RAPD  Analysis. Asian  J  of  BiolSci  2008;1(1):1-10.

9.        Dou Shee HH. Tephrosia Persoon. Flora of china 2010;10:190-193.

10.     Shah  R,  Rumit S,  Chanda  S.  Pharmacognostical and Preliminary Phytochemical Investigation of  Tephrosia purpurea (Linn.)  Pers.  Root  from  Gujarat  Region.  IJPR  2011;3(2):49-50.

11.     Gandhi  H,  Balaraman  R. Evaluation of  Polyherbal  Formulation  ROUTACK  in   Rodent Models  of Anaphylaxis.  IJPR2011;1(2):87-95.

12.     Arsul  VA  ,  Wagh  SR,  Mayee  RA. Hepatoprotective  activity  of  Livergen, a polyherbal formulation  carbon  tetrachloride  induced  hepatotoxicity  in  rats. Int J Pharm Pharm Sci  2011;3(3):228-231.

13.     Patel  AM,  Darade  SS,  Jain  PG,  Kandalkar  AM.  Formulation and Evaluation of Proprietary  Polyherbal Formulation  for their Hepatoprotective  activity. Int  J  Pharm  Tech   Res  2010;2(1):305-309.

14.     Jain  A,  Lodhi  S,  Singhai  AK.  Simultaneous  estimation  of  quercetin  and  rutin  in  Tephrosia purpurea Pers  by  high  performance  thin  layer  chromatography.  Asian  JTrad  Med  2009;4(3):104-109.

15.     Valli  G,  Vasanthi  A,  Vijayalashmi R,  Thanga  TA.IJPRD  2011;3(6):211-217.

16.     Siddiqui  S,  Verma  A,  Rather  AA,  Jabeen  F,Meghvansi  MK.  Preliminary  Phytochemical  Analysis  of  Some  Important  Medicinal  and  Aromatic  plants.  AdvBiol  Res  2009;3(5-6):188-195.

17.     Saraf  MN,  Damre  AS,  Gokhale  AB,  Phadke  AS,  Kulkarni  KR. Studiesbon the immunomodulatory activity of flavonoidal of Tephrosia purpurea.  Fitoterapia  2003;74:257-267.

18.     Shah  R,  Kathad  H,  Sheth  R,  Sheth  N.In  vitro  Antioxidant  Activity  of  Tephrosia purpurea.  Int  J  Pharmacy  PharmSci  2010;2(3):30-33.

19.     Ahmad  VU,  Ali  Z,  Hussaini  SR,  Iqbal  F,  Zahid  M  at  al.,  studied  the  Flavonoids  of Tephrosia purpurea.  Fitoterapia  1999;70:443-445.

20.     Nirmal  SA,  Sonawane  IL,  Dhasade  VV,  Rub  RA,  Mandal  SC.Antioxidant  effect  of  Tephrosia purpurea  roots.  IJPSR  2010;1:57-60.

21.     Rao  EV,  Raju  NR.Occurrence  of  (-)-isolonchocarpin  in  the  roots  of Tephrosia purpurea.  phytochemistry  1979;18:1581-1582.

22.     Rao  EV,  Raju  NR.Two  Flavonoids  from  Tephrosia purpurea,  Phytochemistry,  1984,  23(10),  2339-2342.

23.     Ahmad  S.  Natural occurrence  of Tephrosia  flavones.  Phytochemistry  1986; 25(4):955-958.

24.     Sinha  B,  Natu  AA,  Nanavati  DD. Prenylated  flavonoids  from Tephrosia purpurea seeds.Phytochemistry1982;21(6):1468-1470.

25.     Maurya  R,  Yadav  PP. Furanoflavonoids:  an  overview.  Nat.  Prod.  Rep.,  2005;22:400-424.

26.     Yenesew  A,  Juma  WP,  Akala  HM,  Eyase  FL,  Muiva  LM. Terpurinflavone:  An  antiplasmodial  flavones  from  the  stem  of  Tephrosiapurpurea. Phytochemistry  letters  2011;4:176-178.

27.     Gupta  RK,  Krishnamurti M,  Parthasarathi  J,  Purpurin. A  flavanone  from  Tephrosia purpurea.  Phytochemistry1980;19: 1264.

28.     Parmar  VS,  Rathore  JS,  Jain  R,  Henderson  DA,  Malone  JF.  Occurrence  of  pongamol  as  the  enol  structure  in Tephrosia purpurea.  Phytochemistry,  1989;28(2):591-593.

29.     Gupta  M,  Mazumder  UK,  Gomathi  P,  Selvan  VT. Antimirobial  activity  of  methanol  extracts  of  Plumeria  acuminate  Ait.  leaves  and Tephrosia purpurea. Nat  Prod  Rep  2008;7(2):102-105.

30.     Abayasekara  CL,  Rangama  BNLD,  Panagoda  GJ,  Senanayake  MRDM,  Antimicrobial  activity  of  Tephrosiapurpurea  (Linn.)  Pers.  and  Mimusopselengi (Linn.)  against  some  clinical  bacterial  isolates. J  NatnSci  2009;  37(2):139-145.

31.     Smita  S,  Shwetha  K,  Prabhu  K,  Maradi  R,  Bairy  KL at  al.,  studied  the  Evaluation  of  anti-inflammatory  activity  of  Tephrosia purpurea  in  rats.Asian  Pac  J  Trop  Med  2010;3(3):193-195.

32.     Gopalakrishnan  S,  Vadivel  E,  Dhanalakshmi  K.Anti-inflammatory  and  analgesic  activities  of  Tephrosia purpurea  Linn.  aerial  and  root extracts. J  Phar  Res  2010;3(5):1103-1106.

33.     Rama  Murthy  MS,  Srinivasan  M. Hepatoprotective  effect  of  Tephrosia purpurea  in  experimental  animals. Indian  J  of  Pharmacol  1993;25:34-36.

34.     Jain  A,  Singhai  AK,  Dixit  VK.A  comparative  study  of  ethanol  extract  of  leaves  of  Tephrosiapurpureapers  and  the  flavonoid  isolated  for  hepatoprotective  activity.  Indian  J  Phar Sci  2006;68(6):749-743.

35.     Pavana  P, Sethupathy  S,  Manoharan  S. Antihyperglymic  and  antilipidperoxidative  effects  of Tephrosia purpurea  seed  extract  in  Streptozotocin  induced  diabetic  rats.Indian  JClin Biochem 2007;22(1):  77-83.

36.     Asuntha  G,  Prasannaraju Y,  Sujatha  D,  Prasad  KVSRG.Assessment  ofethanolic  extract  of  Tephrosiapurpurea  (L.)  Pers.,  Fabaceae,  activity  on  lithium-pilocarpine  induced  Status  epilepticus  and  oxidative  stress  in  Wistar  rats.  Braz  JPharmacog  2009;22:56-61.

37.     Das  PK, Chinniah  A,  Mohapatra  S,Goswami  S,  Mahapatra  Aat  al.,  studied  the  potential  of Tephrosia purpurea  as  anti-Helicobacter  pyroliagent.  J  Ethanopharmacol  2009;124:642-645.

38.     Akthar  R,  Ahmad  S,  Shaikh  T,  Mujawar  T,  Khan  M.Antihyperlipidemic  effect  of  ethanolic  extract  of  Tephrosia purpurea Linn  in  dexamethasone  induced  rats.  IJRAP  2011;2(1):264-266.

39.     Deshpande  SS,  Shah  GB,  Parmar  NS. Antiulcer  activity  of  Tephrosia purpurea in  rats. Indian  J Pharmacol  2003;35:168-172.

40.     Soni  K,  Kumar  PS,  Saraf  MN. Antioxidant  activity  of  fraction  of   Tephrosia purpurea Linn. Indian  J  PharmSci  2006; 68(4):234-238.

41.     Singhai  AK,  Santram  L,  Pawar  RS,  Jain  AP.Wound  healing  potential  of   Tephrosia purpurea,  (Linn.)  Pers.  in  rats.  J  Ethnopharmol  2006;108:204-210.

42.     Gokhale  A,  Saraf  MN. Influence  of Ethanolic  Extract  of   Tephrosia purpurea Linn.  on  the  Late-phase  of  Allergic  Reaction.  Indian  J  Pharm  Sci  2000;62(5):356-359.

43.     Kavitha K, Manoharan S. Anticarcinogenic and antilipidperoxidative  effects  of   Tephrosia purpurea (Linn.)  Pers.  in7,12-dimethylbenz(a)anthracene (DMBA)  induced  hamster  buccal  pouch  carcinoma.  Indian J. Pharmacol 2006;38(3):185-89. 

44.     Suvidha  SS,  AnujaP.  Evaluation  of  pharmacognostical,  phytochemical  and  pharmacological  activity  of    Tephrosia purpurea (Linn.).  IJPRD 2009;  1(5):1-4.

45.     Kumar  AS,  Amudha  P,  Kannan CS.  Evaluation  of  anxiolytic  activity  of  hydroalcoholic  activity  of  Tephrosia purpurea (L) Pers  on  Swiss  albino  mice.  IJPSR  2011;2(5):1262-1269. 

 

 

Received on 23.01.2012

Modified on 07.02.2012

Accepted on 12.02.2012

© A&V Publication all right reserved

Research Journal of Pharmacognosy  and Phytochemistry. 4(2): March-April  2012, 134-143